ArticleFrontiers in physiology2012
In Search for Factors that Drive Hantavirus Epidemics.
Article in Frontiers in physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 59 citations in OpenAlex.
- Detection of Puumala hantavirus antigen in human intestine during acute hantavirus infection.PloS one · 2014Trial
- Small rodents, huge impact: A scoping review of EuropeanOne health (Amsterdam, Netherlands) · 2026Review
- Epidemiology and Economic Burden of Puumala Virus Infection in Styria, Austria, 2003 to 2024.Open forum infectious diseases · 2026Article
- Hantavirus infections and small mammal diversity in Chile: No differences between protected and unprotected areas highlight the need for public health strategies.PLoS neglected tropical diseases · 2025Article
- Unraveling the Mechanistic Links Between Species Diversity and Infection Risk From Zoonotic Pathogens With Direct Transmission Among Reservoir Hosts: Rodent-Orthohantavirus Systems as Models.Ecology and evolution · 2025Review
- Impact of Environmental Factors on the Distribution Patterns of Nephropathia Epidemica Cases in Western Europe.Environmental health perspectives · 2025Article
- Ecological determinants driving orthohantavirus prevalence in small mammals of Europe: a systematic review.One health outlook · 2025Review
- Hantavirus in rodents in the United States: Temporal and spatial trends and report of new hosts.Ecosphere (Washington, D.C) · 2025Article
- Range Dynamics of Striped Field Mouse (Biology · 2023Article
- Machine learning identifies straightforward early warning rules for human Puumala hantavirus outbreaks.Scientific reports · 2023Article
- Identification of Dobrava-Belgrade Virus inViruses · 2022Article
- MASTREE+: Time-series of plant reproductive effort from six continents.Global change biology · 2022Article
- How Bank Vole-PUUV Interactions Influence the Eco-Evolutionary Processes Driving Nephropathia Epidemica Epidemiology-An Experimental and Genomic Approach.Pathogens (Basel, Switzerland) · 2020Article
- Article
- Why Hantavirus Prevalence Does Not Always Increase With Host Density: Modeling the Role of Host Spatial Behavior and Maternal Antibodies.Frontiers in cellular and infection microbiology · 2020Article
- Revisiting the genetic diversity of emerging hantaviruses circulating in Europe using a pan-viral resequencing microarray.Scientific reports · 2019Article
- Molecular and epidemiological characteristics of human Puumala and Dobrava-Belgrade hantavirus infections, Germany, 2001 to 2017.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2019Article
- Effects of climate factors on hemorrhagic fever with renal syndrome in Changchun, 2013 to 2017.Medicine · 2019Article
- Spatial dynamics of a zoonotic orthohantavirus disease through heterogenous data on rodents, rodent infections, and human disease.Scientific reports · 2019Article
- Landscape and rodent community composition are associated with risk of hemorrhagic fever with renal syndrome in two cities in China, 2006-2013.BMC infectious diseases · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Europe, hantaviruses (Bunyaviridae) are small mammal-associated zoonotic and emerging pathogens that can cause hemorrhagic fever with renal syndrome (HFRS). Puumala virus, the main etiological agent carried by the bank vole Myodes glareolus is responsible for a mild form of HFRS while Dobrava virus induces less frequent but more severe cases of HFRS. Since 2000 in Europe, more than 3000 cases of HFRS have been recorded, in average, each year, which is nearly double compared to the previous decade. In addition to this upside long-term trend, significant oscillations occur. Epidemic years appear, usually every 2-4 years, with an increased incidence, generally in localized hot spots. Moreover, the virus has been identified in new areas in the recent years. A great number of surveys have been carried out in order to assess the prevalence of the infection in the reservoir host and to identify links with different biotic and abiotic factors. The factors that drive the infections are related to the density and diversity of bank vole populations, prevalence of infection in the reservoir host, viral excretion in the environment, survival of the virus outside its host, and human behavior, which affect the main transmission virus route through inhalation of infected rodent excreta. At the scale of a rodent population, the prevalence of the infection increases with the age of the individuals but also other parameters, such as sex and genetic variability, interfere. The contamination of the environment may be correlated to the number of newly infected rodents, which heavily excrete the virus. The interactions between these different parameters add to the complexity of the situation and explain the absence of reliable tools to predict epidemics. In this review, the factors that drive the epidemics of hantaviruses in Middle Europe are discussed through a panorama of the epidemiological situation in Belgium, France, and Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.